MIRA Pharmaceuticals, Inc.

NASDAQ (USD): MIRA Pharmaceuticals, Inc. (MIRA)

Last Price

1.55

Today's Change

-0.03 (1.89%)

Day's Change

1.54 - 1.62

Trading Volume

209,429

Overview

Market Cap

22 Million

Shares Outstanding

14 Million

Avg Volume

5,694,587

Avg Price (50 Days)

1.66

Avg Price (200 Days)

1.32

PE Ratio

-1.80

EPS

-0.86

Earnings Announcement

11-Nov-2024

Previous Close

1.58

Open

1.56

Day's Range

1.54 - 1.628

Year Range

0.51 - 6.48

Trading Volume

210,122

Price Change Highlight

1 Day Change

-1.90%

5 Day Change

-19.69%

1 Month Change

-27.23%

3 Month Change

103.95%

6 Month Change

63.18%

Ytd Change

30.25%

1 Year Change

-74.34%

3 Year Change

-75.86%

5 Year Change

-75.86%

10 Year Change

-75.86%

Max Change

-75.86%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—General

Description:

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment